Literature DB >> 16079326

Inflammation and resistance to erythropoiesis-stimulating agents--what do we know and what needs to be clarified?

Jana Smrzova1, Jozsef Balla, Peter Bárány.   

Abstract

Resistance to erythropoiesis-stimulating agents (ESA) in patients with chronic kidney disease (CKD) can be associated with evidence of enhanced systemic inflammatory responses. This review considers the inflammatory mechanisms thought to be involved in the development and aetiology of anaemia of CKD that may help our understanding and management of patients with ESA resistance. The potential role of nutritional support and of anti-inflammatory therapies in managing resistance to ESA therapy is discussed and explored.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16079326     DOI： 10.1093/ndt/gfh1109

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


  19 in total

1.  Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.

Authors:  Tetsuya Ogawa; Himiko Shimizu; Ai Kyono; Masayo Sato; Tetsuri Yamashita; Kuniaki Otsuka; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2013-06-27       Impact factor: 2.370

2.  The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

Authors:  Lei Zhang; Jeff Coombes; Elaine M Pascoe; Sunil V Badve; Kim Dalziel; Alan Cass; Philip Clarke; Paolo Ferrari; Stephen P McDonald; Alicia T Morrish; Eugenie Pedagogos; Vlado Perkovic; Donna Reidlinger; Anish Scaria; Rowan Walker; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Redox Rep       Date:  2016-03-04       Impact factor: 4.412

3.  Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.

Authors:  Elísio Costa; Margarida Lima; João Moura Alves; Susana Rocha; Petronila Rocha-Pereira; Elisabeth Castro; Vasco Miranda; Sameiro Faria Maria do; Alfredo Loureiro; Alexandre Quintanilha; Luís Belo; Alice Santos-Silva
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

4.  Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells.

Authors:  Abolfazl Zarjou; Viktória Jeney; Paolo Arosio; Maura Poli; Péter Antal-Szalmás; Anupam Agarwal; György Balla; József Balla
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

5.  Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Authors:  Mingxin Wei; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2007-05-30       Impact factor: 2.370

6.  Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.

Authors:  Samar K M Khalil; H A Amer; Adel M El Behairy; Mohamad Warda
Journal:  J Adv Res       Date:  2016-02-23       Impact factor: 10.479

7.  Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Pablo E Pergola; Matt Devalaraja; Steven Fishbane; Michel Chonchol; Vandana S Mathur; Mark T Smith; Larry Lo; Kurt Herzog; Rahul Kakkar; Michael H Davidson
Journal:  J Am Soc Nephrol       Date:  2020-12-03       Impact factor: 10.121

8.  Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.

Authors:  Jula K Inrig; Suzanne K Bryskin; Uptal D Patel; Murat Arcasoy; Lynda A Szczech
Journal:  BMC Nephrol       Date:  2011-12-12       Impact factor: 2.388

9.  Association of secondary hyperparathyroidism with hemoglobin level in patients with chronic kidney disease.

Authors:  Happy Chutia; Alice Abraham Ruram; Himashree Bhattacharyya; Polina Boruah; Chandan Nath
Journal:  J Lab Physicians       Date:  2013-01

10.  Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism.

Authors:  Lorenzo A Calò; Paul A Davis; Giuseppe Maiolino; Elisa Pagnin; Verdiana Ravarotto; Elena Naso; Gianni Carraro; Agostino Naso
Journal:  Cardiorenal Med       Date:  2015-09-17       Impact factor: 2.041
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.